american society for blood and marrow transplantation

What american society for blood and marrow transplantation does

ASTCT is a nonprofit professional membership society (legally domiciled in the United States and headquartered in Chicago, IL) serving the hematopoietic cell transplantation (HCT), cellular therapy, and gene therapy field. The organization provides its 3,900+ members—including physicians (MD/PhD), advanced practice providers, pharmacists, transplant nurses, administrative staff, and trainees—access to a peer-reviewed journal (Transplantation and Cellular Therapy), evidence-based practice guidelines (delivered via web and a mobile app), continuing education through a Learning Center, 15+ Special Interest Groups, advocacy programming, and a portfolio of annual conferences led by Tandem Meetings (co-hosted with CIBMTR) and the Gene Therapy Summit, Clinical Education Conference, Toxicities Conference, and a 2026-launched Meeting on Immunological Disorders with CBCI. Distribution is community-led through self-serve website enrollment, six international joint membership agreements with regional societies (APBMT, ANZTCT, PBMT, SBMTO, SRTM, SAH), institutional group memberships, and a mobile app ecosystem.

ASTCT operates a membership-fee revenue model supplemented by conference registration, journal subscriptions and open access fees, Corporate Council sponsorships from pharmaceutical and biotech companies (Incyte, Sanofi, Iovance, Johnson & Johnson, Legend Biotech), and education grants. Membership tiers include Regular/Associate ($275/year, $413 extended through 2027), Affiliate ($175/year, $263 extended), Institutional Affiliate ($140/person for groups of 5+), In-Training (Free), and Emeritus (Free). Marketing relies on digital channels (astct.org, newsletters, the ASTCT Talks podcast, Nucleus trending topics, Learning Center), the Tandem Meetings event cycle, and patient education resources. The society is led by CEO/Executive Director Andre Williams and President Margy MacMillan, with no parent company, no PE/VC ownership, and no disclosed funding rounds.

Name

american society for blood and marrow transplantation

Legal name

American Society for Transplantation and Cellular Therapy

Website

https://asbmt.org

Company type

Private

Operating status

Operating

Short description

ASTCT is a nonprofit professional medical society serving 3,900+ members in hematopoietic cell transplantation, cellular therapy, and gene therapy through membership programs, peer-reviewed publications, practice guidelines, advocacy, and annual conferences including Tandem Meetings.

Ownership category

akta.pro rank

Product category

Professional Medical Society Services

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Bone Marrow & Stem Cell Transplant (BMT/HSCT) (HLAKAFAI)

akta.pro secondary industry

Transplantation & Advanced Therapies Pharmaceuticals (incl. Cell & Gene Therapies) (HLAIAAAO)

Keywords

• Professional medical society
• Hematopoietic cell transplantation
• Cellular therapy guidelines
• Clinical education
• Transplantation research

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Dues: Annual membership fees from individual professionals including physicians (MD/PhD), associate members, affiliate members (non-MD/non-PhD such as pharmacists, nurses, administrative staff), in-training members, emeritus members, and institutional affiliate memberships. Extended memberships offered starting June through September provide coverage through December 31 of the following year.
2. Meetings and Conferences: Registration fees for major conferences including Tandem Meetings (with CIBMTR), Gene Therapy Summit, Clinical Education Conference, Toxicities Conference, and various webinars. Members receive exclusive discounted rates.
3. Journal Publications: Subscription to Transplantation and Cellular Therapy journal. Members receive a monthly e-journal subscription and publish at 20% off open access fees.
4. Practice Guidelines App: Mobile application for accessing practice guidelines on the go, supported by an education grant from Sanofi/US.
5. Corporate Sponsorships: Corporate Council sponsorships providing companies visibility and access to the ASTCT membership community.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

The American Society for Blood and Marrow Transplantation (ASTCT) is a professional medical society that advances the field of hematopoietic cell transplantation and cellular therapy. It delivers its mission through membership programs, peer-reviewed scientific publishing, clinical practice guidelines, continuing medical education, and the operation of major scientific meetings for clinicians and researchers.

Product overview

ASTCT is a professional medical society offering a comprehensive portfolio of products and services for the transplantation and cellular therapy field. The organization operates primarily as a membership-based professional society with multiple interconnected offerings: (1) peer-reviewed publications through Transplantation and Cellular Therapy Journal, (2) educational platforms including the Learning Center with CE-accredited courses and webinars, (3) clinical decision support via the Practice Guidelines App with evidence-based guidelines, (4) community engagement through SIG Community Forums and Special Interest Groups, (5) career development services including Career Center and Fellowship Programs, (6) conferences including the Tandem Meetings, Gene Therapy Summit, and Clinical Education Conference, (7) patient education resources including the Master Class Video Series on cGVHD, and (8) various membership tiers providing differential access to these resources. The Nucleus content platform aggregates trending topics and science highlights across CAR T, GVHD, TIL, and other cellular therapy areas. ASTCT Talks podcast extends reach through Spotify, Google Podcasts, and Apple Podcasts distribution.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 3,900+ members served across the HCT and cellular therapy field

Segments7 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

13 partnerships are on record, tiered core, major and supporting.

• Center for International Blood and Marrow Transplant Research (CIBMTR)coreStrategic or Co-development PartnerCIBMTR is the primary co-host of the annual Tandem Meetings | Transplantation & Cellular Therapy, one of the most significant conferences in the field. The partnership brings together the two leading organizations in HCT and cellular therapy research and clinical practice for joint scientific programming and networking.
• European Society for Blood and Marrow Transplantation (EBMT)coreStrategic or Co-development PartnerASTCT and EBMT hold joint meetings including the ASTCT + EBMT Joint Basic and Translational Scientific Meeting and the 6th International Conference on Relapse After Transplant and Cellular Therapy (HSCT²). They also collaborate on clinical practice recommendations such as guidelines for follicular lymphoma.
• IncytemajorGTM or Marketing PartnerIncyte collaborates with ASTCT on a master class video series focused on chronic graft vs. host disease (cGVHD) for patients and healthcare providers. The collaboration is designed to empower patients to identify early signs of cGVHD and encourage meaningful discussions with healthcare teams.
• Sanofi (US)supportingGTM or Marketing PartnerSanofi provides an education grant supporting the ASTCT Practice Guideline App, enabling mobile access to evidence-based clinical guidelines in transplantation and cellular therapy.
• Asia Pacific Blood and Marrow Transplantation (APBMT)supportingStrategic or Co-development PartnerInternational joint membership agreement allowing APBMT members to access ASTCT membership benefits and participate in educational programming.
• Australia and New Zealand Transplant & Cellular Therapies (ANZTCT)supportingStrategic or Co-development PartnerInternational joint membership agreement enabling ANZTCT members to join ASTCT and access member benefits, meetings, and educational resources.
• Pakistan Blood and Marrow Transplant (PBMT)supportingStrategic or Co-development PartnerInternational joint membership agreement providing PBMT members with access to ASTCT membership and resources.
• Sociedade Brasileira de Transplante de Medula Óssea (SBMTO)supportingStrategic or Co-development PartnerInternational joint membership agreement with the Brazilian Society of Bone Marrow Transplantation.
• Societatea Romană de Transplant Medular (SRTM)supportingStrategic or Co-development PartnerInternational joint membership agreement with the Romanian Society for Bone Marrow Transplantation.
• Sociedad Argentina de Hematología (SAH)supportingStrategic or Co-development PartnerInternational joint membership agreement with the Argentine Society of Hematology.
• Iovance BiotherapeuticssupportingGTM or Marketing PartnerIovance sponsors TIL (tumor-infiltrating lymphocyte) therapy content on ASTCT's Nucleus platform, supporting education around this emerging cellular therapy modality.
• Johnson & JohnsonsupportingGTM or Marketing PartnerCorporate sponsor supporting ASTCT educational content and programming in the cellular therapy space.
• Legend BiotechsupportingGTM or Marketing PartnerCorporate sponsor supporting ASTCT educational programming and member resources.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• European Society for Blood and Marrow Transplantation (EBMT): EBMT is the European equivalent professional society serving HCT and cellular therapy clinicians and researchers. It is the most directly comparable peer to ASTCT in scope, membership model, journal (Bone Marrow Transplantation), and annual meetings, and is already an ASTCT research partner.
• Center for International Blood and Marrow Transplant Research (CIBMTR): CIBMTR is the research counterpart organization that co-hosts the Tandem Meetings with ASTCT. It operates the outcomes registry and research infrastructure for the HCT field, making it a tightly coupled peer and partner organization.
• International Society for Cell & Gene Therapy (ISCT): ISCT is the international professional society focused specifically on cell and gene therapy, directly overlapping ASTCT's cellular therapy scope and competing for the same translational researcher and clinician members.
• Foundation for the Accreditation of Cellular Therapy (FACT): FACT accredits HCT and cellular therapy programs and works closely with ASTCT and EBMT on standards. It is a directly adjacent peer serving the same transplant center ecosystem through accreditation rather than membership.
• American Society for Apheresis (ASFA): ASFA is a smaller US professional society serving apheresis practitioners — a core clinical workflow in HCT and cellular therapy — making it a niche but directly overlapping peer in membership and meeting offerings.

Broad incumbents

• American Society of Hematology (ASH): ASH is the much larger US professional society for all hematology clinicians and researchers. It competes for ASTCT's physician members' dues, CME attention, and meeting time, while housing HCT as a major subspecialty track.
• American Society of Clinical Oncology (ASCO): ASCO is the dominant US oncology professional society with overlapping physician members treating hematologic malignancies with HCT and cellular therapy. It represents a broader incumbent competitor for member dues and meeting participation.

Regional players

• Asia-Pacific Blood and Marrow Transplantation Group (APBMT): APBMT is the regional HCT professional society covering the Asia-Pacific region and is already an ASTCT joint-membership partner. It is directly comparable in scope but geographically distinct.
• American Society of Transplant Surgeons (ASTS): ASTS is a US professional society focused on solid organ transplant surgeons — a related but distinct transplant specialty. It is comparable in being a US transplant-focused membership organization, but does not directly overlap ASTCT's BMT/cellular therapy focus.

Others

• National Marrow Donor Program (NMDP / Be The Match): NMDP/Be The Match operates the US marrow donor registry and is an ecosystem participant rather than a professional society peer. It is closely tied to ASTCT members as the source of unrelated donor grafts but serves a fundamentally different mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/asbmt

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about american society for blood and marrow transplantation